Aneesh Mehta MD
- Department of Medicine
Professor
- (404) 727-8435
- aneesh.mehta@emory.edu
-
Emory University School of Medicine
Division of Infectious Diseases
101 Woodruff Cir, WMB 2101
Overview
In July 2009, Dr. Mehta joined the faculty of Emory University. He is a Professor of Medicine in the Division of Infectious Diseases and the Assistant Director of the Transplant Infectious Diseases Section. In 2020, Dr. Mehta was named the Chief of Infectious Diseases Services for Emory University Hospital and Emory University Orthopedic and Spine Hospital.
Dr. Mehta's research and clinical paths have focused on treatment of and protection against infections in immunocompromised hosts, including patients with organ transplants, stem cell transplants, leukemia/lymphoma, and HIV/AIDS.
Dr. Mehta also serves as the Consultant for Occupational Exposure at Emory University's Emory National Primate Center. In this role, he supervises the care of employees at Emory National Primate Research Center who have incurred a work related exposure or injury, including Herpes-B exposures.
Dr. Mehta has served as member of the Emory Serious Communicable Diseases Unit (SCDU) since 2009. In addition, he serves a co-PI for ASPR's National Emerging Special Pathogen Training and Education Center (NETEC) and the Emory lead for Special Pathogen Research Network (SPRN).
Academic Appointment
- Professor of Medicine, Division of Infectious Diseases, Emory University School of Medicine
- Professor of Surgery, Division of Transplant Surgery, Emory University School of Medicine
- Distinguished Physician, Emory University School of Medicine
Education
Degrees
- MD from University of Oklahoma College of Medicine
- BS from Emory University
Research
Focus
- My research area is broadly within clinical and translational Transplant Infectious Diseases, with my primary research aim to develop predictive immunologic and virologic signatures of risk for viral diseases in patients receiving immunosuppressive agents. I primarily employ polychromatic flow cytometry to phenotypically and functionally describe subsets of the protective immune system and quantitative PCR to detect and quantify viral pathogens.
Publications
-
Wrangling Real-World Data: Optimizing Clinical Research Through Factor Selection with LASSO Regression.
Int J Environ Res Public Health Volume: 22
03/21/2025 Authors: Howard KA; Anderson W; Podichetty JT; Gould R; Boyce D; Dasher P; Evans L; Kao C; Kumar VK; Hamilton C -
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients.
Nat Commun Volume: 16 Page(s): 586
01/10/2025 Authors: Pickering H; Schaenman J; Phan HV; Maguire C; Tsitsiklis A; Rouphael N; Higuita NIA; Atkinson MA; Brakenridge S; Fung M -
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans.
Nat Immunol Volume: 26 Page(s): 116 - 130
01/01/2025 Authors: Cortese M; Hagan T; Rouphael N; Wu S-Y; Xie X; Kazmin D; Wimmers F; Gupta S; van der Most R; Coccia M -
Influenza virus infection and aerosol shedding kinetics in a controlled human infection model.
J Virol Volume: 98 Page(s): e0161224
12/17/2024 Authors: Shetty N; Shephard MJ; Rockey NC; Macenczak H; Traenkner J; Danzy S; Vargas-Maldonado N; Arts PJ; Le Sage V; Anderson EJ -
Evaluating Real-World Experience With Maribavir for Treatment of Refractory/Resistant Cytomegalovirus in Renal Transplant Recipients.
Clin Transplant Volume: 38 Page(s): e15480
10/01/2024 Authors: Beechar VB; Phadke VK; Pouch SM; Mehta AK; Karadkhele G; Larsen CP; Woodworth MH -
Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis.
JCI Insight Volume: 9
09/24/2024 Authors: Zamora D; Dasgupta S; Stevens-Ayers T; Edmison B; Winston DJ; Razonable RR; Mehta AK; Lyon GM; Boeckh M; Singh N -
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir.
J Infect Dis Volume: 230 Page(s): 624 - 634
09/23/2024 Authors: Singh K; Rubenstein K; Callier V; Shaw-Saliba K; Rupert A; Dewar R; Laverdure S; Highbarger H; Lallemand P; Huang M-L -
High-Level Isolation: A Landscape Analysis of Global Capabilities and Opportunities to Advance the Field.
Health Secur Volume: 22 Page(s): S17 - S33
09/01/2024 Authors: Herstein JJ; Lukowski J; ElRayes W; Lowe JJ; Mehta AK; Mukherjee V; Stern KL; Carrasco SV; Vasa A; Vasistha S -
Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention.
Emerg Infect Dis Volume: 30 Page(s): 854 - 863
05/01/2024 Authors: Frank MG; Weaver G; Raabe V; State of the Clinical Science Working Group of the National Emerging Pathogens Training; Education Centers Special Pathogens Research Network2; State of the Clinical Science Working Group of the National Emerging Pathogens Training Education Centers Special Pathogens Research Network -
Wait Time Advantage for Transplant Candidates With HIV Who Accept Kidneys From Donors With HIV Under the HOPE Act.
Transplantation Volume: 108 Page(s): 759 - 767
03/01/2024 Authors: Motter JD; Hussain S; Brown DM; Florman S; Rana MM; Friedman-Moraco R; Gilbert AJ; Stock P; Mehta S; Mehta SA